Optimizing HSCT in Blood Cancers

Lori Muffly, MD, MS, Stanford Medicine, Stanford, CA

Recorded on May 12, 2026

Lori Muffly, MD, MS

Professor of Medicine

Division of Blood and Marrow Transplantation & Cellular Therapy

Stanford Medicine

Stanford, CA

In this episode, Dr. Lori Muffly from Stanford Medicine explores how hematopoietic stem cell transplantation (HSCT) continues to play a central role in care, even as cellular therapies evolve. She also discusses recent advances in overall survival and graft versus host disease as well as clinical trials. We also explore barriers to access, the importance of multidisciplinary teams, and resources to support patients and healthcare professionals. Join us for this insightful episode on the important role of HSCT today, and where it’s headed next.

Mentioned on this episode:

www.NMDP.org

www.hematology.org

Additional Blood Cancer United Resources: